The study identifies phenolic compounds in Viburnum urceolatum and evaluates their enzyme inhibitory effects, indicating their potential for therapeutic use.
Two previously undescribed p-hydroxyphenyl glycosides, viburceosides A (1) and B (2), together with thirteen known analogues, were isolated from the fruits of Viburnum urceolatum. Their structures were established through comprehensive analysis of spectroscopic (NMR, HRESIMS) spectra and quantum-chemically calculated ECD spectra. The sugar moieties of the new isolates were determined by hydrolysing the glycosides and analysing monosaccharides as chiral derivatives by HPLC. Enzyme inhibition assays showed compound 4 was the most potent constituent, exhibiting dual inhibitory activity on α-glucosidase and α-amylase, with IC₅₀ values of 5.49 μM and 7.63 μM, respectively. These values indicated that compound 4 was of significantly superior potency to acarbose (IC₅₀ = 26.75 μM and 37.31 μM, respectively). Subsequent molecular docking studies provided insights into the binding modes responsible for this enhanced activity.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: